{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:36:18Z","timestamp":1787510178468,"version":"build-2736575974"},"reference-count":42,"publisher":"The Endocrine Society","issue":"11","license":[{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Hereditary hypophosphatemic disorders such as X-linked hypophosphatemia (XLH) are rare phosphate wasting disorders that cause abnormal bone mineralization, which manifests as bone deformities and dental problems. Pain, stiffness, and fatigue are the main symptoms reported by adult patients with XLH, interfering with their quality of life and activities of daily living. Here we provide a comprehensive evaluation of pain and health related quality of life in patients with XLH.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design and Methods<\/jats:title>\n                    <jats:p>In this cross-sectional study, 49 adult patients with XLH and 42 healthy sex- and age- matched control participants underwent pressure algometry to determine pain sensitivity. In addition, we collected patient-reported outcome data on pain, quality of life, and mental health through the following questionnaires: (1) Brief Pain Inventory-Short Form, (2) SF-36v2\u2122 Health Survey, (3) painDETECT, (4) Functional Assessment of Cancer Therapy\u2014Bone Pain, (4) Pain Catastrophizing Scale, (5) Generalized Anxiety Disorder 7 and (6) Patient Health Questionnaire 9.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Patients with XLH present altered skin but not bone mechanical pressure pain thresholds, which may suggest referred pain through sensitization mechanisms. Questionnaire data highlight significantly higher pain scores in patients with XLH, which correlate with depression scores. Additionally, patients with XLH report decreased quality of life and mental health, increased pain catastrophizing thinking, and anxiety.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our results suggest that using patient-reported outcomes is important to understand the pain phenotype and mental health in patients with XLH and can be helpful to dictate treatment aimed at improving their pain and quality of life.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgaf104","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T15:22:46Z","timestamp":1739892166000},"page":"e3886-e3896","source":"Crossref","is-referenced-by-count":9,"title":["Pain, Quality of Life, and Mental Health in Adults with X-linked Hypophosphatemia: A Cross-sectional Study"],"prefix":"10.1210","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7719-6839","authenticated-orcid":false,"given":"Marta","family":"Diaz-delCastillo","sequence":"first","affiliation":[{"name":"Department of Forensic Medicine, Aarhus University , Aarhus 8200 ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7464-6785","authenticated-orcid":false,"given":"Rasmus Bundgaard","family":"Espersen","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Internal Medicine, Aarhus University Hospital , Aarhus 8200 ,","place":["Denmark"]},{"name":"Department of Clinical Medicine, Aarhus University , Aarhus 8200 ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7561-9217","authenticated-orcid":false,"given":"Signe Sparre","family":"Beck-Nielsen","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Aarhus University , Aarhus 8200 ,","place":["Denmark"]},{"name":"Centre for Rare Diseases, Aarhus University Hospital , Aarhus 8200 ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2152-4247","authenticated-orcid":false,"given":"Lars","family":"Rejnmark","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Internal Medicine, Aarhus University Hospital , Aarhus 8200 ,","place":["Denmark"]},{"name":"Department of Clinical Medicine, Aarhus University , Aarhus 8200 ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2754-0800","authenticated-orcid":false,"given":"Anne-Marie","family":"Heegaard","sequence":"additional","affiliation":[{"name":"Department of Drug Design and Pharmacology, University of Copenhagen , Copenhagen 2100 ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2025,2,19]]},"reference":[{"issue":"2","key":"2025101519580499400_dgaf104-B1","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s11154-008-9075-3","article-title":"Inherited hypophosphatemic disorders in children and the evolving mechanisms of phosphate regulation","volume":"9","author":"Bastepe","year":"2008","journal-title":"Rev Endocr Metab Disord"},{"issue":"2","key":"2025101519580499400_dgaf104-B2","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00590-014-1496-y","article-title":"Hypophosphatemic rickets: etiology, clinical features and treatment","volume":"25","author":"Pavone","year":"2015","journal-title":"Eur J Orthop Surg Traumatol"},{"issue":"2","key":"2025101519580499400_dgaf104-B3","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s00223-010-9373-0","article-title":"Phenotype presentation of hypophosphatemic rickets in adults","volume":"87","author":"Beck-Nielsen","year":"2010","journal-title":"Calcif Tissue Int"},{"issue":"6","key":"2025101519580499400_dgaf104-B4","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/00005792-198911000-00002","article-title":"X-Linked Hypophosphatemia: a clinical, biochemical, and histopathologic assessment of morbidity in adults","volume":"68","author":"Reid","year":"1989","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"2025101519580499400_dgaf104-B5","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13023-019-1014-8","article-title":"FGF23 and its role in X-linked hypophosphatemia-related morbidity","volume":"14","author":"Beck-Nielsen","year":"2019","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"2025101519580499400_dgaf104-B6","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1365-2842.2011.02250.x","article-title":"Periapical and endodontic status of permanent teeth in patients with hypophosphatemic rickets","volume":"39","author":"Andersen","year":"2012","journal-title":"J Oral Rehabil"},{"issue":"7","key":"2025101519580499400_dgaf104-B7","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1007\/s11136-020-02465-x","article-title":"Exploring the burden of X-linked hypophosphatemia: a European multi-country qualitative study","volume":"29","author":"Lo","year":"2020","journal-title":"Qual Life Res"},{"key":"2025101519580499400_dgaf104-B8","volume-title":"Weak Bones, Strong Wills: The Stories of XLH","author":"Inc. The XLH Network, Inc","year":"2017"},{"issue":"8","key":"2025101519580499400_dgaf104-B9","doi-asserted-by":"crossref","first-page":"bvab070","DOI":"10.1210\/jendso\/bvab070","article-title":"Patient-reported complications, symptoms, and experiences of living with X-linked hypophosphatemia across the life-course","volume":"5","author":"Cheung","year":"2021","journal-title":"J Endocr Soc"},{"issue":"5","key":"2025101519580499400_dgaf104-B10","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s40620-024-01962-3","article-title":"X-Linked hypophosphatemia. Data from a Spanish adult population cohort","volume":"37","author":"L\u00f3pez-Romero","year":"2024","journal-title":"J Nephrol"},{"issue":"1","key":"2025101519580499400_dgaf104-B11","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13023-023-02620-w","article-title":"Patient-reported outcomes measures of X-linked hypophosphataemia participants: findings from a prospective cohort study in the UK","volume":"18","author":"Cole","year":"2023","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"2025101519580499400_dgaf104-B12","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/s13023-022-02452-0","article-title":"Health-related quality of life of X-linked hypophosphatemia in Spain","volume":"17","author":"Yanes","year":"2022","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"2025101519580499400_dgaf104-B13","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1530\/EJE-15-0661","article-title":"Impaired quality of life in adults with X-linked hypophosphatemia and skeletal symptoms","volume":"174","author":"Che","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2025101519580499400_dgaf104-B14","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s13023-016-0538-4","article-title":"Health-related quality of life and a cost-utility simulation of adults in the UK with osteogenesis imperfecta, X-linked hypophosphatemia and fibrous dysplasia","volume":"11","author":"Forestier-Zhang","year":"2016","journal-title":"Orphanet J Rare Dis"},{"issue":"8","key":"2025101519580499400_dgaf104-B15","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.jval.2018.01.013","article-title":"Qualitative research to explore the patient experience of X-linked hypophosphatemia and evaluate the suitability of the BPI-SF and WOMAC\u00ae as clinical trial End points","volume":"21","author":"Theodore-Oklota","year":"2018","journal-title":"Value Health"},{"issue":"7","key":"2025101519580499400_dgaf104-B16","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1210\/js.2018-00365","article-title":"The lifelong impact of X-linked hypophosphatemia: results from a Burden of Disease Survey","volume":"3","author":"Skrinar","year":"2019","journal-title":"J Endocr Soc"},{"issue":"2","key":"2025101519580499400_dgaf104-B17","doi-asserted-by":"crossref","first-page":"176","DOI":"10.17294\/2330-0698.1727","article-title":"Giving credence to the experience of X-linked hypophosphatemia in adulthood: an interprofessional mixed-methods study","volume":"7","author":"Hughes","year":"2020","journal-title":"J Patient Cent Res Rev"},{"issue":"9","key":"2025101519580499400_dgaf104-B18","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1007\/s00198-021-05875-w","article-title":"Clinical and molecular characterization of Chilean patients with X-linked hypophosphatemia","volume":"32","author":"Jim\u00e9nez","year":"2021","journal-title":"Osteoporos Int"},{"issue":"4","key":"2025101519580499400_dgaf104-B19","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1507\/endocrj.EJ21-0386","article-title":"Burden of disease of X-linked hypophosphatemia in Japanese and Korean patients: a cross-sectional survey","volume":"69","author":"Ito","year":"2022","journal-title":"Endocr J"},{"key":"2025101519580499400_dgaf104-B20","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.bonr.2016.05.004","article-title":"Effect of four monthly doses of a human monoclonal anti-FGF23 antibody (KRN23) on quality of life in X-linked hypophosphatemia","volume":"5","author":"Ruppe","year":"2016","journal-title":"Bone Rep"},{"key":"2025101519580499400_dgaf104-B21","first-page":"129","article-title":"Pain assessment: global use of the brief pain inventory","volume":"23","author":"Cleeland","year":"1994","journal-title":"Ann Acad Med Singap"},{"issue":"10","key":"2025101519580499400_dgaf104-B22","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1185\/030079906X132488","article-title":"painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain","volume":"22","author":"Freynhagen","year":"2006","journal-title":"Curr Med Res Opin"},{"issue":"2","key":"2025101519580499400_dgaf104-B23","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jpainsymman.2008.08.005","article-title":"Switching breast cancer patients with progressive bone metastases to third-generation bisphosphonates: measuring impact using the functional assessment of cancer therapy-bone pain","volume":"38","author":"Broom","year":"2009","journal-title":"J Pain Symptom Manage"},{"key":"2025101519580499400_dgaf104-B24","first-page":"AS264","article-title":"Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the medical outcomes study","volume":"33","author":"Ware","year":"1995","journal-title":"Med Care"},{"issue":"4","key":"2025101519580499400_dgaf104-B25","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1037\/1040-3590.7.4.524","article-title":"The pain catastrophizing scale: development and validation","volume":"7","author":"Sullivan","year":"1995","journal-title":"Psychol Assess"},{"issue":"10","key":"2025101519580499400_dgaf104-B26","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: the GAD-7","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch Intern Med"},{"issue":"9","key":"2025101519580499400_dgaf104-B27","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J Gen Intern Med"},{"issue":"2","key":"2025101519580499400_dgaf104-B28","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/bcpt.12002","article-title":"A human experimental bone pain model","volume":"112","author":"Andresen","year":"2013","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"2","key":"2025101519580499400_dgaf104-B29","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"2025101519580499400_dgaf104-B30","doi-asserted-by":"crossref","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"key":"2025101519580499400_dgaf104-B31","doi-asserted-by":"crossref","unstructured":"Diaz-delCastillo M. \u00a0Pain, quality of life and mental health in adults with X-linked hypophosphatemia: a cross-sectional study. OSF. 2025. Accessed February 19, 2025. 10.17605\/OSF.IO\/DR59V","DOI":"10.1210\/clinem\/dgaf104"},{"key":"2025101519580499400_dgaf104-B32","first-page":"1163","article-title":"Pain, mood disturbance, and quality of life in patients with multiple myeloma","volume":"28","author":"Poulos","year":"2001","journal-title":"Oncol Nurs Forum"},{"issue":"9","key":"2025101519580499400_dgaf104-B33","doi-asserted-by":"crossref","first-page":"e3682","DOI":"10.1210\/clinem\/dgab282","article-title":"Incidence of complications in 25 adult patients with X-linked hypophosphatemia","volume":"106","author":"Kato","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2025101519580499400_dgaf104-B34","doi-asserted-by":"crossref","first-page":"ziae118","DOI":"10.1093\/jbmrpl\/ziae118","article-title":"Impact of X-linked hypophosphatemic rickets\/osteomalacia on health and quality of life: baseline data from the SUNFLOWER longitudinal, observational cohort study","volume":"8","author":"Namba","year":"2024","journal-title":"JBMR Plus"},{"issue":"10","key":"2025101519580499400_dgaf104-B35","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1210\/JC.2015-2199","article-title":"Conventional therapy in adults with X-linked hypophosphatemia: effects on enthesopathy and dental disease","volume":"100","author":"Connor","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"2025101519580499400_dgaf104-B36","doi-asserted-by":"crossref","first-page":"1104817","DOI":"10.3389\/fneur.2023.1104817","article-title":"Referred pain: characteristics, possible mechanisms, and clinical management","volume":"14","author":"Jin","year":"2023","journal-title":"Front Neurol"},{"issue":"5","key":"2025101519580499400_dgaf104-B37","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jclinepi.2011.09.008","article-title":"US general population norms for telephone administration of the SF-36v2","volume":"65","author":"Maglinte","year":"2012","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"2025101519580499400_dgaf104-B38","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/art.42672","article-title":"A randomized controlled neuroimaging trial of cognitive behavioral therapy for fibromyalgia pain","volume":"76","author":"Lee","year":"2024","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"2025101519580499400_dgaf104-B39","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1097\/j.pain.0000000000000626","article-title":"Cognitive behavioral therapy for chronic pain is effective, but for whom?","volume":"157","author":"Broderick","year":"2016","journal-title":"Pain"},{"issue":"7","key":"2025101519580499400_dgaf104-B40","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41581-019-0152-5","article-title":"Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia","volume":"15","author":"Haffner","year":"2019","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"2025101519580499400_dgaf104-B41","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00223-009-9270-6","article-title":"Survey of the enthesopathy of X-linked hypophosphatemia and its characterization in Hyp mice","volume":"85","author":"Liang","year":"2009","journal-title":"Calcif Tissue Int"},{"issue":"12","key":"2025101519580499400_dgaf104-B42","doi-asserted-by":"crossref","first-page":"bvae184","DOI":"10.1210\/jendso\/bvae184","article-title":"Effect of mutation type on ectopic ossification among adult patients with X-linked hypophosphatemia","volume":"8","author":"Kato","year":"2024","journal-title":"J Endocr Soc"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgaf104\/61988459\/dgaf104.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/11\/e3886\/61988459\/dgaf104.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/11\/e3886\/61988459\/dgaf104.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T23:58:12Z","timestamp":1760572692000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/110\/11\/e3886\/8024223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,19]]},"references-count":42,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,2,19]]},"published-print":{"date-parts":[[2025,10,16]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgaf104","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,11]]},"published":{"date-parts":[[2025,2,19]]}}}